№ files_lp_4_process_2_68009
File format: docx
Character count: 2547
File size: 186 KB
Longitudinal study dataset presenting recruitment flow and demographic, clinical, and psychosocial characteristics of stroke patients over three follow-up periods.
Year:
Not specified
Region / city:
China
Study type:
Longitudinal observational study
Population:
Stroke patients
Sample size:
T1=339, T2=310, T3=279
Variables measured:
Age, gender, marital status, residence status, educational level, place of residence, religious beliefs, medical payment method, number of children, monthly household income, occupation, stroke type, number of strokes, family history of stroke, stroke site, NIHSS score, BMI, course of stroke, number of comorbidities, PSF, resilience
Time points:
T1 (acute hospitalization), T2 (three months after discharge), T3 (six months after discharge)
Currency:
RMB (Chinese yuan)
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / city:
Tianjin, China
Subject:
Stem Cell Therapy, Neurological Function, Ischemic Stroke, Gut Microbiota
Document type:
Research Article
Organization / Institution:
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin Key Laboratory of Translational Research of TCM Prescription and Syndrome
Author:
Zhao LN, Ma SW, Xiao J, Yang LJ, Xu SX, Zhao L
Target audience:
Researchers, Healthcare professionals, Medical practitioners
Period of validity:
Not specified
Approval date:
December 11, 2021
Date of revisions:
July 6, 2021
Publication date:
December 26, 2021
Year:
2024
Region / City:
Australia
Topic:
Orthoptics, Post-Stroke Vision Care
Document Type:
Research Survey
Organization:
La Trobe University
Author:
Associate Professor Connie Koklanis, Associate Professor Meri Vukicevic, Marc Eng
Target Audience:
Orthoptists working with stroke patients in Australia
Period of Action:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / City:
Global
Subject:
Business Analysis, Software Architecture
Document Type:
Educational Resource
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Business Analysts, Software Engineers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Topic:
Software Architecture
Document Type:
Educational Material
Target Audience:
Students, Software Developers
MVC is a software design pattern used to separate an application into three layers:
model, view, and controller, simplifying development, testing, and maintenance by clearly defining the roles and interactions of each component.
Note:
Year
Topic:
Software Development, System Analysis
Document Type:
Instructional Guide
Target Audience:
Business Analysts, Software Developers, Stakeholders
Note:
Year
Organization / institution:
National Centre for Research Methods (NCRM)
Note:
Year
Theme:
IT / Technology, Environmental, Patients, Equipment / Supplies, Staff / People
Document Type:
Diagram
Subject:
Solid-state physics
Topic:
Electrical conductivity of solids
Key Concepts:
Valence band, Conduction band, Forbidden energy gap
Materials Covered:
Insulators, Semiconductors, Conductors
Subtopics:
Intrinsic semiconductor, Extrinsic semiconductor, n-type semiconductor, p-type semiconductor, P–N junction
Physical Parameters:
Electrical conductivity (S/cm), Energy gap (eV)
Examples Mentioned:
Diamond, Silicon, Germanium, Silver, Copper, Aluminum
Processes Discussed:
Doping, Thermal excitation, Charge carrier conduction
Applications Referenced:
Diodes, Transistors, Solar cells, LEDs, Integrated circuits
Source Type:
Educational physics notes
Note:
Year
Topic:
Virus life cycle
Document type:
Educational material
Target audience:
Students, educators
Year:
2021
Region / City:
N/A
Topic:
Networking
Document Type:
Technical Specification
Organization / Institution:
HomePlug Alliance
Author:
N/A
Target Audience:
Engineers, Network Designers
Period of Effect:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Year
Theme:
Plant genetics, gene expression, transgenics
Document type:
Research article
Target audience:
Researchers in plant genetics and biotechnology
Note:
Year
Subject:
Causal loop diagrams, system thinking, electric vehicles, fisheries sustainability
Document Type:
Tutorial / Educational Video
Author:
Freya Palmer
Target Audience:
Researchers, policy makers, environmental scientists
Test SensitivityTP/TP+FN SpecificityTN/FP+TN PPVTP/TP+FP NPVTN/TN+FN Limitations USC pathway1 80.4% 47.2% 3.5% 99.0% low no’s of confirmed CRCAUC=0.65 Raman-CRC blood test* 85.7% 68% 14% 98.7:
//doi.org/10.1111/apt.13846
2. Lung PF, Burling D, Kallarackel L, et al. Implementation of a new CT colonography service:
5 year experience. Clin Radiol. 2014; 69(6): 597-605. doi: 10.1016/j.crad.2014.01.007.3. Bowles CJ, Leicester R, Romaya C, et al. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 2004; 53: 277-283.1) Can you describe the current colorectal cancer USC referral pathway?What are your perceptions of it? (Prompt: memorised or need to refer to it, makes secondary care the gatekeeper for tests, NICE criteria, timeliness, capacity, reassurance to have a guideline to follow, ignores GP’s ‘instinct’)2) Experience of the timeframe from referral to colonoscopy/CTC? How do you manage patient’s expectation? Frequency of repeat consultations between referral and test being done?(Prompt: 37 days average)3) Do you consider your personal volume of USC pathway referrals to be just right, too few, or too many?(Prompt: how much does knowledge of waiting times and resource capacity affect your likelihood to refer a patient? 4). If resources weren’t a problem and if you could wave a magic wand tomorrow what do you think we should do about improving outcomes from CRC? What do you perceive are the barriers to early diagnosis of CRC?(Prompt: Wales is 22nd of 28 in the European league table of CRC survival, screening problems, resources, effective tests, patient choice, patient education). Perception of need for better access to diagnostics in primary care (invasive and non-invasive)5). Which situation would the Raman-CRC blood test be of most value to a GP:-non-specific symptoms? eg constipation, abdominal pain -younger age group below USC age? -all USC patients? What would a USC pathway look like with Raman-CRC embedded? -should it be a secondary care tool ie decision to perform colonoscopy or not: help with triage/prioritisation of referral in secondary care6). Given the Raman-CRC test performance described (on vignette sheet) would you have confidence to use it? If not, what sens/spec/PPV/NPV would it need to have?(Prompt: to seek to understand what is most important for a GP, ability to exclude (NPV) or to correctly identify cancer (PPV))7).What additional clinical trials would you like to see with the blood test before implementation?Further observational work with larger numbers/centres/situations?Release test for use and observe outcomes? RCT test v no test?Comparison with FIT?NICE guidance?1) Can you describe the current colorectal cancer USC referral pathway?What are your perceptions of it? (Prompt: memorised or need to refer to it, makes secondary care the gatekeeper for tests, NICE criteria, timeliness, capacity, reassurance to have a guideline to follow, ignores GP’s ‘instinct’)2) Experience of the timeframe from referral to colonoscopy/CTC? How do you manage patient’s expectation? Frequency of repeat consultations between referral and test being done?(Prompt: 37 days average)3) Do you consider your personal volume of USC pathway referrals to be just right, too few, or too many?(Prompt: how much does knowledge of waiting times and resource capacity affect your likelihood to refer a patient? 4). If resources weren’t a problem and if you could wave a magic wand tomorrow what do you think we should do about improving outcomes from CRC? What do you perceive are the barriers to early diagnosis of CRC?(Prompt: Wales is 22nd of 28 in the European league table of CRC survival, screening problems, resources, effective tests, patient choice, patient education). Perception of need for better access to diagnostics in primary care (invasive and non-invasive)5). Which situation would the Raman-CRC blood test be of most value to a GP:-non-specific symptoms? eg constipation, abdominal pain -younger age group below USC age? -all USC patients? What would a USC pathway look like with Raman-CRC embedded? -should it be a secondary care tool ie decision to perform colonoscopy or not: help with triage/prioritisation of referral in secondary care6). Given the Raman-CRC test performance described (on vignette sheet) would you have confidence to use it? If not, what sens/spec/PPV/NPV would it need to have?(Prompt: to seek to understand what is most important for a GP, ability to exclude (NPV) or to correctly identify cancer (PPV))7).What additional clinical trials would you like to see with the blood test before implementation?Further observational work with larger numbers/centres/situations?Release test for use and observe outcomes? RCT test v no test?Comparison with FIT?NICE guidance?Box S1. GP focus group questions.VIGNETTESAssumptions: Colonoscopy/CTC capacity is the same as present Raman-CRC blood test is routinely available under local guidelines.Raman-CRC test performance is 85.7% sensitivity, 68% specificity, 14% PPV, 98.7% NPV, based on interim analysis of 120 cases and controls.1. 60 y.o. male presents with tiredness. His wife (also in the practice) diagnosed with breast cancer a year ago and just completing adjuvant chemotherapy. He has had time off work himself when she has been ill with side effects. On deeper questioning he describes 6 weeks of increased stool frequency (usually once/day, now 3 times per day). No history of rectal bleeding or mucous, abdominal pain or weight loss. Doesn’t smoke. Abdominal and rectal examinations are normal. Simple diagnostics show he is not anaemic and a stool culture is negative.a) Refer to secondary care on USC pathway without further testingb) Request Raman-CRC blood test to risk stratifyc) Involve patient in decision making? Explore patient expectations/underlying concerns....d) Other?2. A 50 year old patient who is a frequent attender describes three or four episodes of rectal bleeding. This is fresh blood, noticed in the toilet water. No anal pain or itching. No change on bowel habit. Appetite and weight stable. On citalopram for anxiety. No relevant family history. Abdominal examination: appendicectomy scar, nil else. Rectal exam: small skin tags, no masses felt, no blood on glove, no proctoscope available. FBC normal. Action?3. 45 year old female patient, complains of tiredness and self limiting looser stools for 3 weeks, but does have a FH of bowel cancer. Examination normal.Decision made to perform a Raman-CRC blood test. The test returns positive 2 days later. How would you go about discussing this with the patient in the fol
Year:
2023
Region / City:
Washington, DC; Brooklyn, NYC; San Francisco, CA
Topic:
Network Design
Document Type:
Assignment
Organization / Institution:
University of Maryland
Author:
Student
Target Audience:
Chief Information Officer (CIO) of FractalApps
Action Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
Not specified
Manufacturer:
Not specified
System:
Plug-in Hybrid / Electric Vehicle Charging System
Component:
Plugin Charge Control ECU Assembly
Related Components:
Charging Circuit Interrupting Device (CCID); Electric Vehicle Charger Assembly; HV Battery Pack; DC-DC Converter; Power Management Control ECU
Document Type:
Technical System Description
Subject:
Charging Control Logic and Signal Flow
Functions Covered:
Charging Control; AC Input Control; Auxiliary Control; Charging Timer Function; Remote Air Conditioning Control
Voltage Specifications:
Auxiliary Battery Control Voltage 13.5 V
Operating Modes:
Normal Charging; Slow Charging
Signals Referenced:
Charge Start Request Signal; Charge Enable Signal; CPLT Signals; ILMT Signal; Remote Air Conditioning Signal
Year:
2026
School:
Brighton High School
Author:
Matthew Jourden
Document Type:
Tutorial / Instructional Guide
Subject:
Electrical Engineering / Ladder Diagram Design
Target Audience:
High School Students
Components:
Motor (1 Phase), Pilot Light, Push Button, Timer
Voltage:
+24 VDC
Tools Required:
ANIS B Software, HP 5550 Color Printer
Page Layout:
Predefined ladder size, On Center Spacing, Vertical and Horizontal Lines
Procedures:
Ladder creation, adding wires, changing wire types, placing components, rebuilding rungs
Note:
Year
Topic:
Suicide Prevention
Document Type:
Survey
Organization / Institution:
GLS
Target Audience:
Participants of GLS funded training activities
Duration:
6 or 12 months after initial training
Year:
2023
Region / city:
United States
Topic:
Training Evaluation
Document type:
Template
Institution:
Centers for Disease Control and Prevention
Author:
CDC Training and Evaluation Team
Target Audience:
Training developers, evaluators, and learners
Duration:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2024
Region / City:
California
Subject:
Occupational Safety and Health, State Program Evaluation
Document Type:
Report
Institution:
U.S. Department of Labor, Occupational Safety and Health Administration
Author:
U.S. Department of Labor Occupational Safety and Health Administration
Target Audience:
Government agencies, occupational safety professionals
Period of Action:
October 1, 2023 – September 30, 2024
Approval Date:
May 1, 1973
Program Certification Date:
August 19, 1977
Date of Last Revision:
N/A